Guardant Health
GH
#3106
Rank
S$5.30 B
Marketcap
$42.92
Share price
1.73%
Change (1 day)
18.51%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: S$5.30 Billion

As of December 2024 Guardant Health has a market cap of S$5.30 Billion. This makes Guardant Health the world's 3106th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024S$5.30 B22.28%
2023S$4.33 B16.09%
2022S$3.73 B-72.83%
2021S$13.74 B-19.36%
2020S$17.04 B72.3%
2019S$9.89 B124.64%
2018S$4.40 B

End of Day market cap according to different sources

On Dec 21st, 2024 the market cap of Guardant Health was reported to be:

S$5.30 Billion
by Nasdaq info icon info icon
S$5.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$28.96 B 446.17%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.53 B-33.32%๐Ÿ‡บ๐Ÿ‡ธ USA